ReviewFrontiers in oncology2020

Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer.

Colton L Starcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.